Mumbai-based Lupin posted a 52 percent year-on-year increase in consolidated net profit, reaching Rs 359.43 crore for the January-March quarter of FY24
Posts in category Business Standard
GOI announces sale of two dated securities for total notified amount of Rs 20000 crore (07-05-2024)
The Government of India (GoI) has announced the sale (re-issue) of (i) “7.32% Government Security 2030” for a notified amount of Rs. 11,000 crore (nominal) through price based auction using multiple price method and (ii) “7.30% Government Security 2053” for a notified amount of Rs. 9,000 crore (nominal) through price based auction using multiple pricemethod. GoI will have the option to retain additional subscription up to Rs. 2,000 crore against each security. The auctions will be conducted by the Reserve Bank of India, Mumbai Office on May 10, 2024 (Friday).
HPCL, BPCL gain up to 4% on bonus issue plan; IOCL down 2% (07-05-2024)
The boards of directors of HPCL, and BPCL are scheduled to meet on Thursday, May 9, 2024 to consider bonus issue plan
Godrej Consumer records net loss of Rs 1,893 cr in Q4; declares dividend of Rs 10/ share (07-05-2024)
Godrej Consumer Products (GCPL) reported consolidated net loss of Rs 1,893.21 crore in Q4 FY24 as compared with net profit to Rs 452.14 crore in Q4 FY23.
Market at day’s low; broader market tumbles; metal stocks loose sheen (07-05-2024)
At 11:30 IST, the barometer index, the S&P BSE Sensex slipped 552.52 points or 0.74% to 73,353.46. The Nifty 50 declined 182.45 points or 0.81% to 22,260.25.
Thomas Cook introduces Video KYC for seamless foreign exchange services (07-05-2024)
The Video KYC is a simple 2-step process:
Sebi rejects NSE’s proposal to extend trading hours (07-05-2024)
However, concerns were raised by some brokers regarding work-life balance and operational challenges. Traditional brokerages expressed concerns about the impact on manpower requirements, while discount brokers with advanced technology were more receptive to the extension.
Gland Pharma receives USFDA approval for Plerixafor Injection (07-05-2024)
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL), Single-Dose Vial (Product).
Uttam Sugar Mills slumps after weak Q4 numbers (07-05-2024)
Uttam Sugar Mills tumbled 4.06% to Rs 336.60 after the company reported -39.8% drop in net profit to Rs 42.14 crore in Q4 FY24 from Rs 70 crore in Q4 FY23.
Hero MotoCorp Q4 Preview: Company may report up to 27% growth in profit (07-05-2024)
Analysts anticipate a robust quarter for Hero MotoCorp, driven by healthy volume growth and strong sales figures